Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine

Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine

Human fetal progenitor tenocytes (hFPT) produced in defined cell bank systems have recently been characterized and qualified as potential therapeutic cell sources in tendon regenerative medicine. In view of further developing the manufacture processes of such cell-based active pharmaceutical ingredi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Annick Jeannerat, Cédric Peneveyre, Florence Armand, Diego Chiappe, Romain Hamelin, Corinne Scaletta, Nathalie Hirt-Burri, Anthony de Buys Roessingh, Wassim Raffoul, Lee Ann Applegate, Alexis Laurent
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
active pharmaceutical ingredients
cell banking
cell manufacture
hypoxia
human progenitor tenocytes
optimization
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/dec4b8a9e444465f980e2e03665e212a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/dec4b8a9e444465f980e2e03665e212a

Ejemplares similares